Sign in

CIK 0001746473

  • Non-accelerated filer
  • Smaller reporting company

PLIANT THERAPEUTICS, INC.

Sign in to watch
Ticker
PLRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474272481
Phone
+1 650-481-6770
Business address
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-06-14 Coulie Bernard President and CEO Sale −3,757 $32.98 $124K 449,560
2021-06-14 Coulie Bernard President and CEO Sale −243 $33.69 $8K 449,317
2021-05-26 Hull Hans Chief Business Officer Exercise or conversion +4,500 $2.08 $9K 125,246
2021-05-26 Hull Hans Chief Business Officer Exercise or conversion · Stock Option (right to buy) −4,500 12,979
2021-05-14 Coulie Bernard President and CEO Sale −2,997 $28.53 $85K 453,820
2021-05-14 Coulie Bernard President and CEO Sale −503 $29.28 $15K 453,317
2021-04-14 Coulie Bernard President and CEO Sale −3,500 $30.33 $106K 456,817
2021-04-13 Coulie Bernard President and CEO Exercise or conversion +6,000 $2.08 $12K 54,840
2021-04-13 Coulie Bernard President and CEO Exercise or conversion · Stock Option (right to buy) −6,000 337,380
2021-03-18 Lefebvre Eric Chief Medical Officer Sale −11,365 $39.38 $448K 150,715
2021-03-18 Lefebvre Eric Chief Medical Officer Sale −1,135 $39.78 $45K 149,580
2021-03-15 Coulie Bernard President and CEO Sale −1,322 $38.03 $50K 462,495
2021-03-15 Coulie Bernard President and CEO Sale −2,000 $38.75 $78K 460,495
2021-03-15 Coulie Bernard President and CEO Sale −178 $39.69 $7K 460,317
2021-03-05 Cummings Keith Lamont Chief Financial Officer Exercise or conversion +20,000 $2.08 $42K 47,621
2021-03-05 Cummings Keith Lamont Chief Financial Officer Exercise or conversion · Stock Option (right to buy) −20,000 170,097
2021-02-16 Coulie Bernard President and CEO Sale −1,200 $32.10 $39K 466,117
2021-02-16 Coulie Bernard President and CEO Sale −2,100 $32.87 $69K 464,017
2021-02-16 Coulie Bernard President and CEO Sale −200 $34.07 $7K 463,817
2021-01-23 Howes Barbara Chief Human Resource Officer Grant or award · Stock Option (right to buy) +42,500 42,500

Page 16 of 19 · 379 trades